[HTML][HTML] Endothelial cells in emerging viral infections
JH Fosse, G Haraldsen, K Falk… - Frontiers in cardiovascular …, 2021 - frontiersin.org
There are several reasons to consider the role of endothelial cells in COVID-19 and other
emerging viral infections. First, severe cases of COVID-19 show a common breakdown of …
emerging viral infections. First, severe cases of COVID-19 show a common breakdown of …
COVID-19: the vasculature unleashed
LA Teuwen, V Geldhof, A Pasut… - Nature Reviews …, 2020 - nature.com
On the basis of emerging evidence from patients with COVID-19, we postulate that
endothelial cells are essential contributors to the initiation and propagation of severe COVID …
endothelial cells are essential contributors to the initiation and propagation of severe COVID …
Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) poses a persistent threat to global public …
respiratory syndrome-coronavirus-2 (SARS-CoV-2) poses a persistent threat to global public …
Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target
P Ambrosino, IL Calcaterra, M Mosella, R Formisano… - Biomedicines, 2022 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …
The endothelium and COVID-19: an increasingly clear link brief title: endotheliopathy in COVID-19
I Six, N Guillaume, V Jacob, R Mentaverri… - International Journal of …, 2022 - mdpi.com
The endothelium has a fundamental role in the cardiovascular complications of coronavirus
disease 2019 (COVID-19). Infection with severe acute respiratory syndrome coronavirus 2 …
disease 2019 (COVID-19). Infection with severe acute respiratory syndrome coronavirus 2 …
Is COVID-19 an endothelial disease? Clinical and basic evidence
The symptoms most commonly reported by patients affected by coronavirus disease 2019
(COVID-19) include cough, fever, and shortness of breath. However, other major events …
(COVID-19) include cough, fever, and shortness of breath. However, other major events …
[HTML][HTML] SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis
and increased pulmonary vascular permeability leading to edema and hemorrhage. In …
and increased pulmonary vascular permeability leading to edema and hemorrhage. In …
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
JUG Wagner, D Bojkova, M Shumliakivska… - Basic Research in …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019
and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to …
and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to …
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic …
The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
[HTML][HTML] Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
MP Nägele, B Haubner, FC Tanner, F Ruschitzka… - Atherosclerosis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary
complications such as acute myocardial injury, renal failure or thromboembolic events. A …
complications such as acute myocardial injury, renal failure or thromboembolic events. A …